Immune response to mouse mammary tumor virus

Current Opinion in Immunology

Volumn 8, Issue 4, 1996, Pages 498-502

  Luther, Sanjiv A ^a   Acha Orbea, Hans ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN; VIRUS ANTIGEN;

B LYMPHOCYTE; IMMUNE RESPONSE; MOUSE MAMMARY TUMOR ONCOVIRUS; PLASMA CELL; REVIEW; T LYMPHOCYTE; VIRUS IMMUNITY;

EID: 0030218944     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80037-9     Document Type: Article

References (24)

1. Acha-Orbea H, MacDonald HR. Superantigens of mouse mammary tumor virus. Annu Rev Immunol. 13:1995;459-486.
2. Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol. 9:1993;101-128.
3. Squartini F, Olivi M, Bolis GB. Mouse strain and breeding stimulation as factors influencing the effect of thymectomy on mammary tumorigenesis. Cancer Res. 30:1970;2069-2072.
4. Tsubura A, Inaba M, Imai S, Murakami A, Oyaizu N, Yasumizu R, Ohnishi Y, Tanaka H, Morii S, Ikehara S. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo. Cancer Res. 48:1998;6555-6559.
5. Held W, Waanders GA, Shakhov AN, Scarpellino L, Acha-Orbea H, MacDonald HR. Superantigen-induced immune stimulation amplifiers mouse mammary tumor virus infection and allows virus transmission. Cell. 74:1993;529-540.
6. Held W, Waanders GA, Acha-Orbea H, MacDonald HR. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J Exp Med. 180:1994;2347-2351.
7. Lopez DM, Charyulu V, Paul RD. B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations. J Immunol. 134:1985;603-607.
8. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med. 177:1993;359-367.
9. Beutner U, Kraus E, Kitamura D, Rajewsky K, Huber BT. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med. 179:1994;1457-1466.
10. -/- mice do not allow MMTV to complete its life cycle, due to a defect in B cell stimulation. Endogenous MMTV SAgs, on the contrary, do not require this interaction for T-cell deletion to take place.
11. Pucillo C, Cepeda R, Hodes RJ. Expression of an MHC class II transgene determines both superantigenicity expression prevents viral infection. J Exp Med. 178:1993;1441-1445.
12. Held W, Waandeers GA, MacDonald HR, Acha-Orbea H. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus. Int Immunol. 6:1994;1403-1407.
13. Beuter U, McLellan B, Kraus E, Hubert BT. Lack of MMTV superantigen presentation in MHC class II-deficient mice. Cell Immunol. 168:1996;141-147.
14. Modlin CS, Todd GT, Cohen TD, Fairchild RL. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance. of special interest Cell Immunol. 164:1995;217-226 After injection of SAg-expressing B cells from Ig allotype congenic mice into SAg non-expressing recipients, SAg is efficiently presented by recipient B cells but not by donor B cells. This indicates transfer of SAg from donor to host. Moreover, the host B cells presenting the SAg are induced to differentiate into antibody-secreting cells.
15. a. J Exp Med. 170:1989;595-600.
16. Pullen AM, Marrack P, Kapper JW. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature. 335:1988;796-801.
17. Golovkina TV, Chervonsky A, Dudley JP, Ross SR. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell. 69:1992;637-645.
18. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature. 367:1994;425-428.
19. -/- mice can be infected with MMTV and transmit the virus normally. After MMTV infection of adult mice, however, T-cell and B-cell responses are reduced.
20. Champagne E, Scarpellino L, Lane P, Acha-Orbea H. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination. of special interest Eur J Immunol. 1996; Lack of costimulation through CD28 and CTLA-4 leads to a normal MMTV-induced T-B interaction. In mice transgenic for a soluble CTLA-4 molecule, clonal deletion of SAg-reactive T cells and systemic infection are strongly reduced.
21. Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain. J Immunol. 154:1995;6219-6226.
22. Golovkina TV, Dudley JP, Jaffe AB, Ross SR. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc Natl Acad Sci USA. 92:1995;4828-4832.
23. Papiernik M, Pontoux C, Golstein P. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice. of special interest Eur J Immunol. 25:1995;1517-1523 Young Fas-deficient mice (lpr) show normal clonal deletion after MMTV infection, demonstrating that this mechanism of death is less important for MMTV SAg-mediated apoptosis.
24. Krummenacher C, Diggelmann H, Acha-Orbea H. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen. J Virol. 70:1996;3026-3031.